CLASSYS Inc
CLASSYS Inc. provides medical aesthetics devices worldwide. The company offers ULTRAFORMER MPT, a solution for eyebrow lifting; ULTRAFORMER III, an ultrasound surgical device used for tissue coagulation in eyelid lifting, and for skin tightening and improving subcutaneous tissue elasticity in the face (cheeks), abdomen, and thighs; VOLNEWMER, a monopolar radiofrequency therapeutic equipment used … Read more
Market Cap & Net Worth: CLASSYS Inc (214150)
CLASSYS Inc (KQ:214150) has a market capitalization of $2.33 Billion (₩3.42 Trillion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #8136 globally and #186 in its home market, demonstrating a -1.69% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CLASSYS Inc's stock price ₩52300.00 by its total outstanding shares 65333438 (65.33 Million).
CLASSYS Inc Market Cap History: 2015 to 2026
CLASSYS Inc's market capitalization history from 2015 to 2026. Data shows growth from $87.45 Million to $2.33 Billion (36.40% CAGR).
Index Memberships
CLASSYS Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.49% | #45 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.49% | #45 of 1384 |
Weight: CLASSYS Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
CLASSYS Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CLASSYS Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
CLASSYS Inc's market cap is 0.01 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.02x
CLASSYS Inc's market cap is 0.02 times its annual earnings
1.95x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $87.02 Million | $27.24 Billion | $80.85 Million | 0.00x | 1.08x |
| 2017 | $181.58 Million | $34.87 Billion | -$5.13 Billion | 0.01x | N/A |
| 2018 | $178.72 Million | $47.48 Billion | $14.86 Billion | 0.00x | 0.01x |
| 2019 | $621.07 Million | $81.13 Billion | $33.39 Billion | 0.01x | 0.02x |
| 2020 | $678.55 Million | $76.46 Billion | $38.16 Billion | 0.01x | 0.02x |
| 2021 | $831.14 Million | $100.60 Billion | $43.80 Billion | 0.01x | 0.02x |
| 2022 | $818.44 Million | $141.80 Billion | $75.38 Billion | 0.01x | 0.01x |
| 2023 | $1.68 Billion | $180.12 Billion | $74.23 Billion | 0.01x | 0.02x |
| 2024 | $2.13 Billion | $242.94 Billion | $97.88 Billion | 0.01x | 0.02x |
Competitor Companies of 214150 by Market Capitalization
Companies near CLASSYS Inc in the global market cap rankings as of March 19, 2026.
Key companies related to CLASSYS Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
CLASSYS Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, CLASSYS Inc's market cap moved from $87.45 Million to $ 2.33 Billion, with a yearly change of 36.40%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩2.33 Billion | -4.04% |
| 2025 | ₩2.43 Billion | +14.38% |
| 2024 | ₩2.13 Billion | +26.23% |
| 2023 | ₩1.68 Billion | +105.81% |
| 2022 | ₩818.44 Million | -1.53% |
| 2021 | ₩831.14 Million | +22.49% |
| 2020 | ₩678.55 Million | +9.26% |
| 2019 | ₩621.07 Million | +247.51% |
| 2018 | ₩178.72 Million | -1.57% |
| 2017 | ₩181.58 Million | +108.66% |
| 2016 | ₩87.02 Million | -0.50% |
| 2015 | ₩87.45 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CLASSYS Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.33 Billion USD |
| MoneyControl | $2.33 Billion USD |
| MarketWatch | $2.33 Billion USD |
| marketcap.company | $2.33 Billion USD |
| Reuters | $2.33 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.